BRIEF published on 02/29/2024 at 20:11, 2 years 3 months ago BRAIN Biotech AG Announces Issuance of EUR 5 Million Convertible Bond Convertible Bonds Shareholder Rights Financial Strategy BRAIN Biotech AG Corporate Financing
BRIEF published on 02/29/2024 at 20:11, 2 years 3 months ago BRAIN Biotech AG annonce l'émission d'une obligation convertible de 5 millions d'euros Stratégie Financière BRAIN Biotech SA Liens Convertibles Financement D'entreprise Droits Des Actionnaires
PRESS RELEASE published on 02/29/2024 at 20:06, 2 years 3 months ago EQS-Adhoc: BRAIN Biotech AG: Issuance of EUR 5 million convertible bond with exclusion of subscription rights BRAIN Biotech AG issues EUR 5 million convertible bond without subscription rights, to be issued on 5 March 2024. Bonds have 6.52% interest rate and due for repayment in 2026 Convertible Bond BRAIN Biotech AG Subscription Rights Interest Rate Repayment
BRIEF published on 02/28/2024 at 07:30, 2 years 4 months ago BRAIN Biotech AG : Bilan du premier trimestre de l'exercice 2023/24 Croissance Organique Rapport Financier BRAIN Biotech AG BioScience BioProduits
BRIEF published on 02/28/2024 at 07:30, 2 years 4 months ago BRAIN Biotech AG: Review of the first quarter of the 2023/24 financial year Financial Report Organic Growth BRAIN Biotech AG BioScience BioProducts
PRESS RELEASE published on 02/28/2024 at 07:30, 2 years 4 months ago 3M FY 23/24: BRAIN Biotech looks optimistic to stay on the growth path for fiscal year 2023/24 BRAIN Biotech AG reports optimistic outlook for fiscal year 2023/24 with strong start in BioScience business. Quarterly report includes details on revenue and segment performance Revenue Growth Financial Performance BRAIN Biotech AG Fiscal Year 2023/24 BioScience Business
PRESS RELEASE published on 09/28/2023 at 10:30, 2 years 9 months ago BRAIN Biotech AG: BRAIN Biotech AG´s Akribion Genomics team wins first prize at the “BioRiver Boost!” startup competition
PRESS RELEASE published on 09/14/2023 at 10:30, 2 years 9 months ago BRAIN Biotech AG: BRAIN Biotech AG’s Akribion Genomics technology receives patent approval for its groundbreaking nuclease G-dase E®
PRESS RELEASE published on 09/12/2023 at 15:45, 2 years 9 months ago BRAIN Biotech AG: Scientist from BRAIN Biotech AG receives VAAM Innovation Award for the discovery of a novel CRISPR nuclease family
PRESS RELEASE published on 08/30/2023 at 07:30, 2 years 9 months ago BRAIN Biotech AG reports solid 9M numbers despite ongoing high R&D investments and more challenging economic conditions
Published on 06/27/2026 at 16:50, 23 hours 49 minutes ago Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security
Published on 06/27/2026 at 01:40, 1 day 14 hours ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 1 day 16 hours ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 1 day 17 hours ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 1 day 17 hours ago Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/27/2026 at 00:05, 1 day 16 hours ago EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 1 day 16 hours ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 1 day 17 hours ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 1 day 17 hours ago EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 1 day 17 hours ago EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE
